Human cytomegalovirus may be involved in colorectal cancer

November 14, 2002

Preliminary findings of a study in this week's issue of THE LANCET suggest that a common human virus may play a part in the cellular processes involved in the development of colorectal cancer.

Colorectal cancer is the second most frequent cause of death from cancer in many developed countries; most tumours arise sporadically with no clear cause or genetic predisposition. Human cytomegalovirus (CMV) is a widespread virus that is not usually associated with illness among people with a healthy immune response. Laboratory studies have shown that CMV can disrupt cellular processes with the potential to promote malignant growth, particularly affecting colorectal cancer-cell development. Charles S Cobbs from the Birmingham VA Medical Center and University of Alabama, Birmingham, USA, and colleagues assessed whether gene products of human CMV could be detected in colorectal cancers.

Specimens of colorectal polyps, adenocarcinomas, and adjacent normal cells were obtained from 29 people. Two specific human CMV proteins were detected in around 80% of two groups of polyps and in around 85% of two groups of colorectal cancer samples.

Charles S Cobbs comments: "Human cytomegalovirus nucleic acids and proteins can be found that specifically localise to neoplastic cells in human colorectal polyps and adenocarcinomas, and virus infection can induce important oncogenic pathways in colon-cancer cells. In view of the many cellular modulatory properties of this virus, our data justify further studies to establish whether human cytomegalovirus participates in pathogenesis of colorectal cancer."
Contact: Associate Professor Charles S Cobbs MD, Departments of Surgery and Cell Biology,
University of Alabama at Birmingham (UAB) Medical Center,
MEB 519, 1813 6th Avenue South, Birmingham, AL 35294, USA;
T) 205-934-1674;
F) 205-975-6088;

Bob Shepard, UAB Media Relations;
T) 205-934-8934;


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to